Dr. Bishoy M. Faltas on the role of genomic testing in bladder cancer

Test your knowledge of these often-overlooked but essential aspects of genetic and genomic testing.

The inclusion of the test is supported by more than 25 studies demonstrating its clinical utility, including 2 studies published earlier this year.

Test your knowledge of this quiz on the Canadian Urological Association's recommendations for genomic profiling of tumors in prostate cancer.

Test your knowledge of this quiz on the Canadian Urological Association's recommendations for germline genetic testing in prostate cancer management.

“Our study highlights the potential of epigenomic profiling from a simple blood draw to provide a real-time, non-invasive readout of PSMA expression that corresponds with treatment response," says Jacob E. Berchuck, MD.

Data demonstrated wide variation in the proportion of patients recommended for testing and showed that barriers to testing remain.